- Research works
- 1 ▲ 203% vs 2013–17
- Citations
- 11 8.3 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 75% world 28%
Not ranked overall: Revive Therapeutics (Canada) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Revive Therapeutics (Canada) publish most on?
By volume in 2022–2025: Pharmacological Receptor Mechanisms and Effects, SARS-CoV-2 and COVID-19 Research and Tryptophan and brain disorders.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Pharmacological Receptor Mechanisms and Effects Molecular Biology 0 works
- 2 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
- 3 Tryptophan and brain disorders Biological Psychiatry 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
Other research institutions in Vaughan
- Optech (Canada)
- Toronto and Region Conservation Authority
- Sciex (Canada)
- Passat (Canada)
- HydraTek (Canada)
- Progressive Waste Solutions (Canada)
- ITS Electronics (Canada)
- Mircom Technologies (Canada)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.